PharmaCyte Biotech (PMCB) Return on Assets [ROA] (2009 - 2026)
PharmaCyte Biotech's Return on Assets [ROA] was -15.17% in fiscal Q1 2027 (quarter ended Jul 31, 2026), down 9.44 percentage points from -5.73% a year earlier and down 3.24 percentage points from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2026 (ended Apr 30, 2026), Return on Assets [ROA] at PharmaCyte Biotech came in at -12.01%, down 6.86 percentage points from FY2025.
- Return on Assets [ROA] shows a five-year change of +41.43 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Assets [ROA] was -5.15% in FY2025 (+2.54 pp), -7.69% in FY2024 (-2.18 pp), -5.51% in FY2023 (+3.13 pp) and -8.64% in FY2022 (+44.80 pp).
- The fiscal Q1 2027 figure marks the lowest quarterly Return on Assets [ROA] since fiscal Q1 2022.
- Compared with a year earlier, Return on Assets [ROA] was higher in four of the last eight quarters, with an average year-over-year change of -2.42 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was fiscal Q1 2023 (a gain of 48.32 percentage points); the worst was fiscal Q1 2027 (a drop of 9.44 percentage points).
- Per Business Quant data, PMCB's Return on Assets [ROA] in the three fiscal quarters before Q1 2027 was -11.93% (Q4 2026), -8.05% (Q3 2026) and -6.56% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - | -15.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -15.17% |
| Apr 30, 2026 | -11.93% |
| Jan 31, 2026 | -8.05% |
| Oct 31, 2025 | -6.56% |
| Jul 31, 2025 | -5.73% |
| Apr 30, 2025 | -5.98% |
| Jan 31, 2025 | -9.24% |
| Oct 31, 2024 | -7.74% |
| Jul 31, 2024 | -7.14% |
| Apr 30, 2024 | -7.80% |
| Jan 31, 2024 | -3.84% |
| Oct 31, 2023 | -3.54% |
| Jul 31, 2023 | -5.45% |
| Apr 30, 2023 | -5.98% |
| Jan 31, 2023 | -7.19% |
| Oct 31, 2022 | -6.66% |
| Jul 31, 2022 | -5.34% |
| Apr 30, 2022 | -4.64% |
| Jan 31, 2022 | -4.18% |
| Oct 31, 2021 | -7.67% |
API Access
PharmaCyte Biotech Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();